Mimedx (MDXG) EPS (Diluted) (QoQ) (2011 - 2024)
Mimedx (MDXG) EPS (Diluted) (QoQ) (2011 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mimedx | 615.09 Mn | 455.31 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -6.01% |
| Sep 30, 2024 | -55.13% |
| Jun 30, 2024 | 95.95% |
| Mar 31, 2024 | -80.34% |
| Dec 31, 2023 | 418.44% |
| Sep 30, 2023 | -8.76% |
| Jun 30, 2023 | 304.85% |
| Mar 31, 2023 | -144.00% |
| Dec 31, 2022 | 180.95% |
| Sep 30, 2022 | 19.62% |
| Jun 30, 2022 | -2.34% |
| Mar 31, 2022 | -753.96% |
| Dec 31, 2021 | 64.16% |
| Sep 30, 2021 | -18.97% |
| Jun 30, 2021 | 67.01% |
| Mar 31, 2021 | 46.03% |
| Dec 31, 2020 | 65.18% |
| Sep 30, 2020 | -511.89% |
| Jun 30, 2020 | -74.66% |
| Mar 31, 2020 | 35.87% |